| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2B | $12.1B | $12.2B | $12.7B | $11.1B | $2.6B | $2.7B | $2.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.4B | $4.1B | $2.9B | $4.8B | $4.4B | $1.0B | $1.0B | $1.1B |
| Net Income | $2.9B | $2.6B | $1.8B | $3.3B | $3.0B | $0.7B | $0.7B | $0.7B |
| EPS (Basic) | $12.76 | $11.58 | $8.04 | $13.92 | $12.16 | $2.65 | $2.56 | $2.59 |
| EPS (Diluted) | $12.75 | $11.57 | $8.02 | $13.88 | $12.11 | $2.64 | $2.55 | $2.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.2B | $43.7B | $41.7B | $38.9B | $38.5B | $38.0B | $37.9B | $36.2B |
| Current Assets | $3.2B | $3.2B | $3.3B | $2.0B | $2.2B | $2.3B | $2.1B | $1.9B |
| Cash & Equivalents | $1.5B | $1.6B | $1.6B | $0.5B | $0.8B | $1.1B | $0.6B | $0.4B |
| Total Liabilities | $29.7B | $29.4B | $28.9B | $26.2B | $24.9B | $23.2B | $22.7B | $20.9B |
| Current Liabilities | $3.8B | $3.5B | $2.6B | $2.6B | $2.5B | $2.2B | $2.3B | $2.6B |
| Stockholders' Equity | $15.5B | $14.3B | $12.8B | $12.7B | $13.6B | $14.8B | $15.2B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $4.1B | $3.2B | $4.2B | $4.3B | $3.6B | $3.9B | $3.7B |
| Investing Cash Flow | $-2.6B | $-2.8B | $-2.2B | $-1.6B | $-1.2B | $-1.2B | $-1.8B | $-1.7B |
| Capital Expenditures | $2.2B | $2.4B | $2.3B | $1.9B | $1.5B | $1.5B | $2.0B | $2.0B |
| Financing Cash Flow | $-1.9B | $-1.2B | $0.1B | $-3.0B | $-3.3B | $-1.9B | $-2.0B | $-2.3B |